Schedule 13G ownership disclosure
VERTEX PHARMACEUTICALS INC COM
Security class unavailable · CUSIP: 92532F100
Event date: 2014-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 17,194,032
- Percent of class
- 7.1500%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000902219-15-000465
- Form type
- SC 13G
- Filer
- VERTEX PHARMACEUTICALS INC / MA
- CIK
- CIK 875320
- Filed
- Feb 12, 2015
- Reporting period
- Dec 31, 2014
- Description
- Schedule 13G beneficial ownership